QCM
ABBV icon

Quantinno Capital Management’s AbbVie ABBV Stock Holding History

Quantinno Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$207M Buy
952,090
+182,393
+24% +$40.5M 0.35% 28
2025
Q4 		$176M Buy
769,697
+161,579
+27% +$36.8M 0.35% 26
2025
Q3 		$141M Buy
608,118
+215,427
+55% +$43.9M 0.38% 29
2025
Q2 		$72.9M Buy
392,691
+86,440
+28% +$16.1M 0.31% 33
2025
Q1 		$64.2M Buy
306,251
+116,820
+62% +$22.7M 0.42% 28
2024
Q4 		$33.7M Buy
189,431
+31,871
+20% +$5.86M 0.33% 36
2024
Q3 		$31.1M Buy
157,560
+54,769
+53% +$10.2M 0.4% 31
2024
Q2 		$17.6M Buy
102,791
+767
+0.8% +$127K 0.32% 41
2024
Q1 		$18.6M Buy
102,024
+35,789
+54% +$6.17M 0.4% 35
2023
Q4 		$10.3M Buy
66,235
+5,305
+9% +$773K 0.36% 34
2023
Q3 		$9.08M Buy
60,930
+21,692
+55% +$3.18M 0.41% 30
2023
Q2 		$5.29M Sell
39,238
-5,894
-13% -$864K 0.3% 48
2023
Q1 		$7.19M Buy
45,132
+3,491
+8% +$534K 0.48% 24
2022
Q4 		$6.73M Buy
41,641
+15,636
+60% +$2.4M 0.5% 26
2022
Q3 		$3.49M Buy
26,005
+4,375
+20% +$628K 0.45% 28
2022
Q2 		$3.31M Buy
21,630
+4,369
+25% +$668K 0.48% 26
2022
Q1 		$2.8M Buy
17,261
+3,958
+30% +$575K 0.43% 34
2021
Q4 		$1.8M Buy
+13,303
New +$1.57M 0.33% 63
2019
Q3 		– Sell
-9,568
Closed -$696K – 371
2019
Q2 		$696K Buy
+9,568
New +$752K 0.41% 38
2019
Q1 		– Sell
-4,335
Closed -$400K – 363
2018
Q4 		$400K Buy
+4,335
New +$381K 0.33% 110

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Quantinno Capital Management's ABBV Position: Q1 2026 in Review

Quantinno Capital Management increased its AbbVie (ABBV) stake by 24% in Q1 2026, buying an estimated $40.5M and bringing the position to 952,090 shares worth $207M. The position accounts for 0.35% of the portfolio, ranked #28.

Quantinno Capital Management first reported a position in ABBV in Q4 2018 and has held it in 20 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Quantinno Capital Management held 952,090 shares of AbbVie worth $207M as of Q1 2026.
  • Quantinno Capital Management bought 182,393 AbbVie shares in Q1 2026, an estimated $40.5M.
  • AbbVie made up 0.35% of Quantinno Capital Management's portfolio in Q1 2026, its #28 holding.
  • Quantinno Capital Management first reported a position in AbbVie in Q4 2018 and has held it in 20 quarters since.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.